SEC Form 4 · accession 0000950103-16-010539
CASI Pharmaceuticals, Inc. · CASI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Quan Zhou
10% Owner
IDG-Accel China Growth Fund III L.P.
10% Owner
Chi Sing Ho
10% Owner
IDG-Accel China III Investors L.P.
10% Owner
Period of report
Mar 7, 2013
Accepted (ET)
Jan 27, 2016 · 9:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000895051
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF3,F1 | Mar 7, 2013 | P | 972,708 | $2.40 | A | 5,091,438 | D | |
| Common StockF3,F2 | Mar 7, 2013 | P | 68,958 | $2.40 | A | 360,947 | I | See Explanation of Responses |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF3,F1 | $2.91 | Mar 7, 2013 | P | 486,354 | A | Sep 4, 2013 | Sep 4, 2016 | Common Stock | 486,354 | 1,298,354 | D |
| WarrantF3,F2 | $2.91 | Mar 7, 2013 | P | 34,479 | A | Sep 4, 2013 | Sep 4, 2016 | Common Stock | 34,479 | 92,044 | I |
Explanation of responses
- F1These securities are directly owned by IDG-Accel China Growth Fund III L.P. ("IDG-Accel Growth") and may be deemed to be indirectly beneficially owned by the other reporting persons. IDG-Accel China Growth Fund III Associates L.P. ("IDG-Accel Associates") is the general partner of IDG-Accel Growth. IDG-Accel China Growth Fund GP III Associates Ltd. ("IDG-Accel GP") is the general partner of both IDG-Accel Associates and IDG-Accel China III Investors L.P. ("IDG-Accel Investors"). Chi Sing Ho and Quan Zhou are shareholders and directors of IDG-Accel GP. Pursuant to a securities purchase agreement dated as of March 1, 2013 by and among the Issuer and certain investors (the "Purchase Agreement"), IDG-Accel Growth purchased 972,708 shares of common stock and warrants to purchase 486,354 shares of common stock of the Issuer.
- F2These securities are directly owned by IDG-Accel Investors and may be deemed to be indirectly beneficially owned by the other reporting persons. Pursuant to the Purchase Agreement, IDG-Accel Investors purchased 68,958 shares of common stock and warrants to purchase 34,479 shares of common stock of the Issuer.
- F3The shares of common stock and the warrants were issued in units consisting of one share of common stock and a warrant to purchase 0.5 shares of common stock. The purchase price was $2.40 per unit. The filing of this statement by the reporting persons shall not be deemed an admission that such persons are, for purposes of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this statement.